https://www.selleckchem.com/pr....oducts/rituximab.htm
05), with lower education levels influencing patients symptom perception and disease control. Moreover, a significant difference in the evaluation of asthma control was found between ACT and GINA assessment of symptom control (p0.05). 0.05). Responses to ACT single items showed a statistically significant difference between patients with lower and higher education levels in ACT items n°3 and 5, (p less then 0.05), with lower education levels influencing patients symptom perception and disease control. Moreover, a significant diffe